Abbott Molecular Inc. is a genomic disease management company, engages in the development and marketing of clinical laboratory products, which provide information critical to the evaluation and management of cancer, prenatal disorders, and other genetic diseases.
Company Growth (employees)
Illinois City, US
Size (employees)
75,000 (est)+2%
Abbott was founded in 1991 and is headquartered in Illinois City, US

Key People at Abbott

Miles D. White

Miles D. White

Thomas C. Freyman

Thomas C. Freyman

Stephen Fussell

Stephen Fussell

Executive Vice President, Human Resources

Abbott Office Locations

Abbott has offices in Illinois City, Sao Paulo, Shanghai, Beijing and in 5 other locations
Illinois City, US (HQ)
Abbott Park
Québec, CA
8401 Trans-Canada Highway, Saint-Laurent
Maidenhead, GB
Abbott House, Vanwall Business Park, Vanwall Road
Wiesbaden, DE
Abbott GmbH & Co. KG, Max-Planck-Ring 2
Seoul, KR
Samtan Bldg., 3rd Floor, 421 YoungDong-Daero, Kangnam-Ku
Tokyo, JP
3-5-27, Mita, Minato-ku

Abbott Data and Metrics

Abbott Financial Metrics

Abbott's revenue was reported to be $20.9 b in FY, 2016 which is a 2% increase from the previous period.

Revenue (FY, 2016)

20.9 b

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

11.8 b

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

1.4 b

EBIT (FY, 2016)

3.2 b

Market capitalization (15-Aug-2017)

85.4 b

Cash (31-Dec-2016)

18.6 b


88.8 b
Abbott's current market capitalization is $85.4 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016


21.8 b20.2 b20.4 b20.9 b

Revenue growth, %


Cost of goods sold

10 b9.2 b8.7 b9 b

Gross profit

11.8 b11 b11.7 b11.8 b

Gross profit Margin, %


Operating expense total

9.2 b17.6 b17.5 b17.7 b


2.6 b2.6 b2.9 b3.2 b

EBIT margin, %


Interest expense

157 m150 m163 m431 m

Interest income

67 m77 m105 m99 m

Income tax expense

53 m797 m577 m350 m

Net Income

2.6 b2.3 b4.4 b1.4 b
USDFY, 2013FY, 2014FY, 2015FY, 2016


3.5 b4.1 b5 b18.6 b

Accounts Receivable

4 b3.6 b3.4 b3.2 b


2.7 b2.6 b2.6 b2.4 b

Current Assets

19.2 b15.3 b14.2 b26.8 b


12.9 b12.6 b12.4 b12.4 b


9.8 b10.1 b9.6 b7.7 b

Total Assets

43 b41.3 b41.2 b52.7 b

Accounts Payable

1 b1.1 b1.1 b1.2 b

Dividends Payable

341 m362 m383 m391 m

Total Debt

6.6 b7.8 b9 b22 b

Current Liabilities

9.5 b10.5 b9.2 b6.7 b

Debt to Assets Ratio

0.2 x0.2 x0.2 x0.4 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2.6 b2.3 b4.4 b1.4 b

Accounts Receivable

113 m195 m171 m177 m


(154 m)(297 m)(257 m)(98 m)

Accounts Payable

256 m225 m742 m652 m

Cash From Operating Activities

3.3 b3.7 b3 b3.2 b

Purchases of PP&E

1.1 b1.1 b1.1 b1.1 b

Cash From Investing Activities

3.9 b(202 m)406 m248 m

Short-term Borrowings

1.3 b1.8 b

Long-term Borrowings

303 m577 m2.5 b14.9 b

Dividends Paid

(882 m)(1.3 b)(1.4 b)(1.5 b)

Cash From Financing Activities

6.7 b2.7 b2.2 b11.1 b

Interest Paid

148 m182 m166 m181 m

Income Taxes Paid

1 b448 m631 m620 m
USDY, 2016


27.9 x


27.7 x


279.9 k


0.4 x

Abbott Operating Metrics

FY, 2014FY, 2015FY, 2016


10 k1.5 k1.5 k

New Product Launches


Abbott Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
AlereApril 15, 2017$5.3 b
St. Jude MedicalApril 28, 2016$25 b
Kalila MedicalApril 06, 2016
AlereFebruary 02, 2016$5.8 b

Abbott Market Value History

Traffic Overview of Abbott

Abbott Online and Social Media Presence

Abbott Company Life and Culture

You may also be interested in